Duration of antibiotic therapy in critically ill patients: a randomized controlled trial of a clinical and C-reactive protein-based protocol versus an evidence-based best practice strategy without biomarkers.
Isabela Nascimento BorgesRafael CarneiroRafael BergoLarissa MartinsEnrico ColosimoCarolina OliveiraSaulo SaturninoMarcus Vinícius AndradeCecilia RavettiVandack Nobrenull nullPublished in: Critical care (London, England) (2020)
ClinicalTrials.gov Identifier: NCT02987790. Registered 09 December 2016.